Edwards Lifesciences (EW) Short term Debt (2009 - 2018)

Edwards Lifesciences has reported Short term Debt for 7 years, with the latest figure at $598.6 million in Q1 2018.

• For the quarter ending Q1 2018, Short term Debt changed N/A year-over-year to $598.6 million; the trailing twelve-month figure through Mar 2018 stood at $598.6 million (changed N/A YoY), and the FY2017 full-year result was $51.7 million, changed N/A from the prior year.
• Short term Debt for Q1 2018 stood at $598.6 million, up from $51.7 million in the prior quarter.
• The five-year high for Short term Debt was $598.6 million in Q1 2018, with the low at $2.2 million in Q3 2014.
• Average Short term Debt over 3 years is $139.3 million, with a median of $41.5 million recorded in 2017.
• Peak annual rise in Short term Debt reached 80.15% in 2014, while the deepest fall reached 80.15% in 2014.
• Tracing EW's Short term Debt over 3 years: stood at $2.6 million in 2014, then soared by 1888.46% to $51.7 million in 2017, then surged by 1057.83% to $598.6 million in 2018.
• The last three Short term Debt figures came in at $598.6 million (Q1 2018), $51.7 million (Q4 2017), and $41.5 million (Q3 2017), per Business Quant data.

Peer Comparison